Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Coeptis Therapeutics Holdings (COEPW) Leases (2021 - 2025)

Coeptis Therapeutics Holdings has reported Leases over the past 5 years, most recently at $18399.0 for Q4 2025.

  • Quarterly results put Leases at $18399.0 for Q4 2025, down 69.22% from a year ago — trailing twelve months through Dec 2025 was $18399.0 (down 69.22% YoY), and the annual figure for FY2025 was $18399.0, down 69.22%.
  • Leases for Q4 2025 was $18399.0 at Coeptis Therapeutics Holdings, down from $29104.0 in the prior quarter.
  • Over the last five years, Leases for COEPW hit a ceiling of $97571.0 in Q4 2023 and a floor of $17925.0 in Q4 2021.
  • Median Leases over the past 5 years was $49427.0 (2023), compared with a mean of $49729.9.
  • Biggest five-year swings in Leases: surged 228.67% in 2022 and later plummeted 69.22% in 2025.
  • Coeptis Therapeutics Holdings' Leases stood at $17925.0 in 2021, then surged by 228.67% to $58914.0 in 2022, then surged by 65.62% to $97571.0 in 2023, then crashed by 38.73% to $59783.0 in 2024, then plummeted by 69.22% to $18399.0 in 2025.
  • The last three reported values for Leases were $18399.0 (Q4 2025), $29104.0 (Q3 2025), and $39564.0 (Q2 2025) per Business Quant data.